{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T20:53:15Z","timestamp":1790974395703,"version":"4.1.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Institute on Aging","award":["AG081170"],"award-info":[{"award-number":["AG081170"]}],"id":[{"id":"https:\/\/ror.org\/049v75w11","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01 AG066162"],"award-info":[{"award-number":["R01 AG066162"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/049v75w11","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01 NS029993"],"award-info":[{"award-number":["R01 NS029993"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl. Stroke Res."],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Inflammation contributes to cerebrovascular disease, but prospective studies of broad immune marker panels and incident stroke are limited. We aimed to identify plasma immune markers independently associated with incident stroke. Stroke-free Northern Manhattan Study participants aged\u2009\u2265\u200950\u00a0years had 60 plasma immune-related proteins measured by Luminex. Least absolute shrinkage and selection operator (LASSO) Cox regression selected markers associated with incident all-cause stroke. Selected markers were tested in Cox models of stroke risk sequentially adjusted for vascular risk, cardiac comorbidities, interleukin-6, interleukin-1\u03b2, tumor necrosis factor-\u03b1, and white matter hyperintensity volume (WMHV). Ischemic stroke was a secondary outcome, and bootstrap resampling provided internal validation. Among 1175 participants (mean age 70\u2009\u00b1\u20099\u00a0years; 60% women; 67% Hispanic), 130 strokes, 101 (78%) ischemic, occurred over a median of 14\u00a0years. LASSO selected only C-X-C motif chemokine ligands 9 and 10 (CXCL9 and CXCL10). Each 1-standard deviation greater CXCL10 was associated with 20% greater all-cause stroke risk after adjustment for vascular risk, cardiac comorbidities, and inflammatory cytokines (HR 1.20; 95%CI 1.04\u20131.38). The association persisted after WMHV adjustment (HR 1.18; 95%CI 1.02\u20131.37), was similar for ischemic stroke (HR 1.19; 95%CI 1.01\u20131.41), and was stable across bootstrap resamples. CXCL9 was not independently associated with stroke. In a multiethnic urban aging cohort followed prospectively for over a decade, baseline plasma CXCL10, also known as interferon-\u03b3\u2013induced protein 10 (IP-10), was independently associated with incident stroke. CXCL10 may mark interferon-\u03b3\u2013responsive immune activity linked to cerebrovascular vulnerability. Whether CXCL10 signals a modifiable pathway for stroke prevention warrants investigation.<\/jats:p>","DOI":"10.1007\/s12975-026-01498-7","type":"journal-article","created":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T08:01:46Z","timestamp":1790928106000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Chemokine CXCL10 and Incident Stroke Risk in the Northern Manhattan Study"],"prefix":"10.1007","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-1743-8492","authenticated-orcid":false,"given":"Mohammad","family":"Nafeli Shahrestani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8957-8615","authenticated-orcid":false,"given":"Christian","family":"Agudelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1416-632X","authenticated-orcid":false,"given":"Hannah","family":"Gardener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3831-5433","authenticated-orcid":false,"given":"Emir","family":"Veledar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1431-5789","authenticated-orcid":false,"given":"Jose A.","family":"Santiago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3031-4196","authenticated-orcid":false,"given":"Marco R.","family":"Di Tullio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Della-Morte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9600-0633","authenticated-orcid":false,"given":"Botagoz","family":"Aimagambetova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Gutierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7572-3092","authenticated-orcid":false,"given":"Mady","family":"Hornig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell S. V.","family":"Elkind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9797-6215","authenticated-orcid":false,"given":"Clinton B.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E.","family":"Tom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7115-9815","authenticated-orcid":false,"given":"Tatjana","family":"Rundek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,2]]},"reference":[{"issue":"3","key":"1498_CR1","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1161\/CIRCRESAHA.116.308398","volume":"120","author":"AK Boehme","year":"2017","unstructured":"Boehme AK, Esenwa C, Elkind MSV. Stroke risk factors, genetics, and prevention. Circ Res. 2017;120(3):472\u201395.","journal-title":"Circ Res"},{"issue":"3","key":"1498_CR2","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1161\/01.STR.22.3.312","volume":"22","author":"PA Wolf","year":"1991","unstructured":"Wolf PA, D\u2019Agostino RB, Belanger AJ, Kannel WB. Probability of stroke: a risk profile from the Framingham study. Stroke. 1991;22(3):312\u20138.","journal-title":"Stroke"},{"issue":"5","key":"1498_CR3","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1189\/jlb.1109766","volume":"87","author":"R Jin","year":"2010","unstructured":"Jin R, Yang G, Li G. Inflammatory mechanisms in ischemic stroke: role of inflammatory cells. J Leukoc Biol. 2010;87(5):779\u201389.","journal-title":"J Leukoc Biol"},{"issue":"5","key":"1498_CR4","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1161\/STROKEAHA.122.036946","volume":"53","author":"E Candelario-Jalil","year":"2022","unstructured":"Candelario-Jalil E, Dijkhuizen RM, Magnus T. Neuroinflammation, stroke, blood-brain barrier dysfunction, and imaging modalities. Stroke. 2022;53(5):1473\u201386.","journal-title":"Stroke"},{"issue":"7","key":"1498_CR5","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1161\/CIRCRESAHA.118.311378","volume":"123","author":"Z Ungvari","year":"2018","unstructured":"Ungvari Z, Tarantini S, Donato AJ, Galvan V, Csiszar A. Mechanisms of vascular aging. Circ Res. 2018;123(7):849\u201367.","journal-title":"Circ Res"},{"issue":"9","key":"1498_CR6","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1161\/01.STR.0000086466.32421.F4","volume":"34","author":"P Cherian","year":"2003","unstructured":"Cherian P, Hankey GJ, Eikelboom JW, Thom J, Baker RI, McQuillan A, et al. Endothelial and platelet activation in acute ischemic stroke and its etiological subtypes. Stroke. 2003;34(9):2132\u20137.","journal-title":"Stroke"},{"issue":"16","key":"1498_CR7","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1212\/WNL.0b013e3181bd10bc","volume":"73","author":"MSV Elkind","year":"2009","unstructured":"Elkind MSV, Luna JM, Moon YP, Liu KM, Spitalnik SL, Paik MC, et al. High-sensitivity C-reactive protein predicts mortality but not stroke. Neurology. 2009;73(16):1300\u20137.","journal-title":"Neurology"},{"issue":"4","key":"1498_CR8","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1161\/STROKEAHA.113.002289","volume":"45","author":"JM Luna","year":"2014","unstructured":"Luna JM, Moon YP, Liu KM, Spitalnik S, Paik MC, Cheung K, et al. High-sensitivity C-reactive protein and interleukin-6\u2013dominant inflammation and ischemic stroke risk. Stroke. 2014;45(4):979\u201387.","journal-title":"Stroke"},{"issue":"8","key":"1498_CR9","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1161\/CIRCRESAHA.122.320110","volume":"130","author":"K Hochrainer","year":"2022","unstructured":"Hochrainer K, Yang W. Stroke proteomics: from discovery to diagnostic and therapeutic applications. Circ Res. 2022;130(8):1145\u201366.","journal-title":"Circ Res"},{"issue":"21","key":"1498_CR10","doi-asserted-by":"publisher","first-page":"e2182","DOI":"10.1212\/WNL.0000000000207242","volume":"100","author":"R Kalani","year":"2023","unstructured":"Kalani R, Bartz TM, Psaty BM, Elkind MSV, Floyd JS, Gerszten RE, et al. Plasma proteomic associations with incident ischemic stroke in older adults. Neurology. 2023;100(21):e2182-90.","journal-title":"Neurology"},{"issue":"23","key":"1498_CR11","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.023330","volume":"10","author":"L Lind","year":"2021","unstructured":"Lind L, Zanetti D, Ingelsson M, Gustafsson S, \u00c4rnl\u00f6v J, Assimes TL. Large-scale plasma protein profiling of incident myocardial infarction, ischemic stroke, and heart failure. J Am Heart Assoc. 2021;10(23):e023330.","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"1498_CR12","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGEN.123.004233","volume":"16","author":"L Lind","year":"2023","unstructured":"Lind L, Titova O, Zeng R, Zanetti D, Ingelsson M, Gustafsson S, et al. Plasma protein profiling of incident cardiovascular diseases: a multisample evaluation. Circ Genom Precis Med. 2023;16(6):e004233.","journal-title":"Circ Genom Precis Med"},{"issue":"5","key":"1498_CR13","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1002\/ana.70011","volume":"98","author":"MC Johansen","year":"2025","unstructured":"Johansen MC, Chen J, Walker KA, Wang Z, Wang W, Chen LY, et al. Proteomics and the risk of incident embolic and thrombotic stroke. Ann Neurol. 2025;98(5):1125\u201335.","journal-title":"Ann Neurol"},{"issue":"2","key":"1498_CR14","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1161\/STROKEAHA.124.048654","volume":"56","author":"X Gan","year":"2025","unstructured":"Gan X, Yang S, Zhang Y, Ye Z, Zhang Y, Xiang H, et al. Large-scale plasma proteomics profiles for predicting ischemic stroke risk in the general population. Stroke. 2025;56(2):456\u201364.","journal-title":"Stroke"},{"issue":"3","key":"1498_CR15","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.3233\/JAD-201370","volume":"80","author":"CB Wright","year":"2021","unstructured":"Wright CB, DeRosa JT, Moon MP, Strobino K, DeCarli C, Cheung YK, et al. Race\/ethnic disparities in mild cognitive impairment and dementia: the Northern Manhattan Study. J Alzheimers Dis. 2021;80(3):1129\u201338.","journal-title":"J Alzheimers Dis"},{"key":"1498_CR16","doi-asserted-by":"crossref","unstructured":"Nafeli Shahrestani M, Gardener H, Veledar E, Agudelo C, Elkind MSV, Gutierrez J, Wright CB, Tom SE, Rundek T. Chemokines CXCL9 and CCL2 in relation to cerebral white matter disease, cognitive decline, and dementia. Neurol Open Access2 2026; 2(1):e000065.","DOI":"10.1212\/WN9.0000000000000065"},{"issue":"12","key":"1498_CR17","doi-asserted-by":"publisher","first-page":"3030","DOI":"10.1161\/STROKEAHA.123.044237","volume":"54","author":"D Yang","year":"2023","unstructured":"Yang D, Liu M, Khasiyev F, Rundek T, Del Brutto VJ, Cheung K, et al. Immune markers are associated with asymptomatic intracranial large artery stenosis and future vascular events in NOMAS. Stroke. 2023;54(12):3030\u20137.","journal-title":"Stroke"},{"issue":"1","key":"1498_CR18","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.atherosclerosis.2004.11.015","volume":"180","author":"MSV Elkind","year":"2005","unstructured":"Elkind MSV, Rundek T, Sciacca RR, Ramas R, Chen H-J, Boden-Albala B, et al. Interleukin-2 levels are associated with carotid artery intima-media thickness. Atherosclerosis. 2005;180(1):181\u20137.","journal-title":"Atherosclerosis"},{"issue":"4","key":"1498_CR19","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s12975-026-01477-y","volume":"17","author":"F Khasiyev","year":"2026","unstructured":"Khasiyev F, Liu M, Hornig M, Shahrestani MN, Wright CB, Elkind MSV, et al. Association between inflammatory biomarkers and carotid ultrasound parameters in the Northern Manhattan Stroke Study. Transl Stroke Res. 2026;17(4):90.","journal-title":"Transl Stroke Res"},{"issue":"5","key":"1498_CR20","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1161\/STROKEAHA.111.641043","volume":"43","author":"H Gardener","year":"2012","unstructured":"Gardener H, Rundek T, Wright CB, Elkind MSV, Sacco RL. Dietary sodium and risk of stroke in the Northern Manhattan Study. Stroke. 2012;43(5):1200\u20135.","journal-title":"Stroke"},{"issue":"1","key":"1498_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/srep26996","volume":"6","author":"EJ Breen","year":"2016","unstructured":"Breen EJ, Tan W, Khan A. The statistical value of raw fluorescence signal in Luminex xMAP based multiplex immunoassays. Sci Rep. 2016;6(1):26996.","journal-title":"Sci Rep"},{"key":"1498_CR22","first-page":"450","volume":"77\u2013110","author":"KK Wallman","year":"1977","unstructured":"Wallman KK, Hodgdon J. Race and ethnic standards for Federal statistics and administrative reporting. Stat Report. 1977;77\u2013110:450\u20134.","journal-title":"Stat Report"},{"issue":"10","key":"1498_CR23","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1161\/01.STR.0000142374.33919.92","volume":"35","author":"RL Sacco","year":"2004","unstructured":"Sacco RL, Anand K, Lee H-S, Boden-Albala B, Stabler S, Allen R, et al. Homocysteine and the risk of ischemic stroke in a triethnic cohort. Stroke. 2004;35(10):2263\u20139.","journal-title":"Stroke"},{"issue":"7","key":"1498_CR24","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1161\/01.STR.0000075294.98582.2F","volume":"34","author":"S-H Suk","year":"2003","unstructured":"Suk S-H, Sacco RL, Boden-Albala B, Cheun JF, Pittman JG, Elkind MS, et al. Abdominal obesity and risk of ischemic stroke: the Northern Manhattan Stroke Study. Stroke. 2003;34(7):1586\u201392.","journal-title":"Stroke"},{"issue":"15","key":"1498_CR25","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.124.035691","volume":"13","author":"TA Ariko","year":"2024","unstructured":"Ariko TA, Aimagambetova B, Gardener H, Gutierrez J, Elkind MS, Wright CB, et al. Estimated pulse-wave velocity and magnetic resonance imaging markers of cerebral small-vessel disease in the NOMAS. J Am Heart Assoc. 2024;13(15):e035691.","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"1498_CR26","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.3233\/JAD-190925","volume":"73","author":"T Rundek","year":"2020","unstructured":"Rundek T, Gardener H, Dias Saporta AS, Loewenstein DA, Duara R, Wright CB, et al. Global vascular risk score and CAIDE Dementia Risk Score predict cognitive function in the Northern Manhattan Study. J Alzheimers Dis. 2020;73(3):1221\u201331.","journal-title":"J Alzheimers Dis"},{"issue":"24","key":"1498_CR27","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1016\/j.jacc.2009.07.047","volume":"54","author":"RL Sacco","year":"2009","unstructured":"Sacco RL, Khatri M, Rundek T, Xu Q, Gardener H, Boden-Albala B, et al. Improving global vascular risk prediction with behavioral and anthropometric factors: the multiethnic NOMAS (Northern Manhattan Cohort Study). J Am Coll Cardiol. 2009;54(24):2303\u201311.","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"1498_CR28","doi-asserted-by":"publisher","first-page":"e953","DOI":"10.1161\/CIR.0000000000001401","volume":"153","author":"SS Khan","year":"2026","unstructured":"Khan SS, Greenland P, Hayman LL, Khera R, Navar AM, Pencina MJ, et al. Criteria to assess the predictive and clinical utility of novel models, biomarkers, and tools for risk of cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2026;153(11):e953\u201370.","journal-title":"Circulation"},{"key":"1498_CR29","doi-asserted-by":"publisher","DOI":"10.4097\/kja.19087","author":"JH Kim","year":"2019","unstructured":"Kim JH. Multicollinearity and misleading statistical results. Korean J Anesthesiol. 2019. https:\/\/doi.org\/10.4097\/kja.19087.","journal-title":"Korean J Anesthesiol"},{"key":"1498_CR30","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/5902947","author":"V Dusi","year":"2016","unstructured":"Dusi V, Ghidoni A, Ravera A, De Ferrari GM, Calvillo L. Chemokines and heart disease: a network connecting cardiovascular biology to immune and autonomic nervous systems. Mediators Inflamm. 2016. https:\/\/doi.org\/10.1155\/2016\/5902947.","journal-title":"Mediators Inflamm"},{"issue":"9","key":"1498_CR31","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1161\/CIRCULATIONAHA.123.064974","volume":"149","author":"S Prapiadou","year":"2024","unstructured":"Prapiadou S, \u017divkovi\u0107 L, Thorand B, George MJ, van der Laan SW, Malik R, et al. Proteogenomic data integration reveals CXCL10 as a potentially downstream causal mediator for IL-6 signaling on atherosclerosis. Circulation. 2024;149(9):669\u201383.","journal-title":"Circulation"},{"key":"1498_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2023.1294450","volume":"16","author":"Y Guo","year":"2023","unstructured":"Guo Y, Sun H, Hou S, Zhang W, Liu H, Zhu L, et al. Inflammatory cytokines and stroke and its subtypes: a genetic correlation and two-sample Mendelian randomization study. Front Mol Neurosci. 2023;16:1294450.","journal-title":"Front Mol Neurosci"},{"issue":"12","key":"1498_CR33","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1212\/WNL.0b013e31822dc7c8","volume":"77","author":"F Canou\u00ef-Poitrine","year":"2011","unstructured":"Canou\u00ef-Poitrine F, Luc G, Mallat Z, Machez E, Bingham A, Ferrieres J, et al. Systemic chemokine levels, coronary heart disease, and ischemic stroke events: the PRIME study. Neurology. 2011;77(12):1165\u201373.","journal-title":"Neurology"},{"key":"1498_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1834236","volume":"17","author":"H Pan","year":"2026","unstructured":"Pan H, Zheng H, Li M. Clinical retrospective study on serum sCD163 and CXCL10 in the immune microenvironment of carotid atherosclerosis: association with inflammatory cytokines, immune cell subsets, and disease progression. Front Immunol. 2026;17:1834236.","journal-title":"Front Immunol"},{"issue":"1","key":"1498_CR35","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s12035-024-04279-1","volume":"62","author":"E Klimiec-Moskal","year":"2025","unstructured":"Klimiec-Moskal E, Koceniak P, Weglarczyk K, Slowik A, Siedlar M, Dziedzic T. Circulating chemokines and short- and long-term outcomes after ischemic stroke. Mol Neurobiol. 2025;62(1):421\u20138.","journal-title":"Mol Neurobiol"},{"issue":"2","key":"1498_CR36","doi-asserted-by":"publisher","first-page":"92","DOI":"10.5152\/eurasianjmed.2017.17022","volume":"49","author":"M Amin","year":"2017","unstructured":"Amin M, Vakilian A, Mahmoodi MH, Hassanshahi G, Falahati-Pour SK, Dolatabadi MR, et al. Circulatory levels of C-X-C motif chemokine ligands 1, 9, and 10 are elevated in patients with ischemic stroke. Eurasian J Med. 2017;49(2):92\u20136.","journal-title":"Eurasian J Med"},{"issue":"1","key":"1498_CR37","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1186\/s12967-025-06498-z","volume":"23","author":"A Vignoli","year":"2025","unstructured":"Vignoli A, Sticchi E, Piccardi B, Palumbo V, Sarti C, Sodero A, et al. Predicting reperfusion injury and functional status after stroke using blood biomarkers: the STROKELABED study. J Transl Med. 2025;23(1):491.","journal-title":"J Transl Med"},{"issue":"1","key":"1498_CR38","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s10565-026-10177-0","volume":"42","author":"Y Lai","year":"2026","unstructured":"Lai Y, Lin P, Zhang K, Hong W, Zheng M, Wu L, et al. Multi-omics analysis and experimental validation reveal the IRF7-CXCL10 axis as a master regulator of microglial PCD in ischemic stroke. Cell Biol Toxicol. 2026;42(1):67.","journal-title":"Cell Biol Toxicol"},{"key":"1498_CR39","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c3666","volume":"341","author":"S Debette","year":"2010","unstructured":"Debette S, Markus HS. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ. 2010;341:c3666.","journal-title":"BMJ"},{"key":"1498_CR40","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ctrv.2017.11.007","volume":"63","author":"R Tokunaga","year":"2018","unstructured":"Tokunaga R, Zhang W, Naseem M, Puccini A, Berger MD, Soni S, et al. CXCL9, CXCL10, CXCL11\/CXCR3 axis for immune activation - a target for novel cancer therapy. Cancer Treat Rev. 2018;63:40\u20137.","journal-title":"Cancer Treat Rev"},{"issue":"5","key":"1498_CR41","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.yexcr.2010.12.017","volume":"317","author":"JR Groom","year":"2011","unstructured":"Groom JR, Luster AD. CXCR3 in T cell function. Exp Cell Res. 2011;317(5):620\u201331.","journal-title":"Exp Cell Res"},{"key":"1498_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1556196","volume":"16","author":"R Huo","year":"2025","unstructured":"Huo R, Jiang Y, Zhang L, Du S, Zhou D. CXCR3 inhibitors for therapeutic interventions: current status and perspectives. Front Pharmacol. 2025;16:1556196.","journal-title":"Front Pharmacol"},{"key":"1498_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01932","volume":"9","author":"V Szentes","year":"2018","unstructured":"Szentes V, Gazdag M, Szokodi I, D\u00e9zsi CA. The role of CXCR3 and associated chemokines in the development of atherosclerosis and during myocardial infarction. Front Immunol. 2018;9:1932.","journal-title":"Front Immunol"},{"issue":"8","key":"1498_CR44","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1002\/jcp.24337","volume":"228","author":"I Chrobak","year":"2013","unstructured":"Chrobak I, Lenna S, Stawski L, Trojanowska M. Interferon-\u03b3 promotes vascular remodeling in human microvascular endothelial cells by upregulating endothelin (ET)-1 and transforming growth factor (TGF) \u03b22. J Cell Physiol. 2013;228(8):1774\u201383.","journal-title":"J Cell Physiol"},{"issue":"1","key":"1498_CR45","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.tcm.2013.06.003","volume":"24","author":"I Voloshyna","year":"2014","unstructured":"Voloshyna I, Littlefield MJ, Reiss AB. Atherosclerosis and interferon-\u03b3: new insights and therapeutic targets. Trends Cardiovasc Med. 2014;24(1):45\u201351.","journal-title":"Trends Cardiovasc Med"},{"key":"1498_CR46","doi-asserted-by":"crossref","unstructured":"Metzemaekers M, Vanheule V, Janssens R, Struyf S, Proost P. Overview of the Mechanisms that May Contribute to the Non-Redundant Activities of Interferon-Inducible CXC Chemokine Receptor 3 Ligands. Frontiers in Immunol; 2018;8: 1970.","DOI":"10.3389\/fimmu.2017.01970"},{"issue":"12","key":"1498_CR47","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"PM Ridker","year":"2017","unstructured":"Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med. 2017;377(12):1119\u201331.","journal-title":"N Engl J Med"},{"issue":"19","key":"1498_CR48","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","volume":"383","author":"M Nidorf Stefan","year":"2020","unstructured":"Nidorf Stefan M, Fiolet Aernoud TL, Mosterd A, Eikelboom John W, Schut A, Opstal Tjerk SJ, et al. Colchicine in patients with chronic coronary disease. N Engl J Med. 2020;383(19):1838\u201347.","journal-title":"N Engl J Med"},{"issue":"12","key":"1498_CR49","doi-asserted-by":"publisher","first-page":"6503","DOI":"10.4049\/jimmunol.164.12.6503","volume":"164","author":"N Marx","year":"2000","unstructured":"Marx N, Mach F, Sauty A, Leung JH, Sarafi MN, Ransohoff RM, et al. Peroxisome proliferator-activated receptor-\u03b3 activators inhibit IFN-\u03b3-induced expression of the T cell-active CXC chemokines IP-10, Mig, and I-TAC in human endothelial cells. J Immunol. 2000;164(12):6503\u20138.","journal-title":"J Immunol"},{"issue":"9","key":"1498_CR50","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1179\/1743132811Y.0000000039","volume":"33","author":"D Della-Morte","year":"2011","unstructured":"Della-Morte D, Moussa I, Elkind MS, Sacco RL, Rundek T. The short-term effect of atorvastatin on carotid plaque morphology assessed by computer-assisted gray-scale densitometry: a pilot study. Neurol Res. 2011;33(9):991\u20134.","journal-title":"Neurol Res"},{"issue":"5","key":"1498_CR51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0005263","volume":"4","author":"O Grip","year":"2009","unstructured":"Grip O, Janciauskiene S. Atorvastatin reduces plasma levels of chemokine (CXCL10) in patients with Crohn\u2019s disease. PLoS ONE. 2009;4(5):e5263.","journal-title":"PLoS ONE"},{"key":"1498_CR52","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.cytogfr.2025.05.003","volume":"84","author":"AA Bufi","year":"2025","unstructured":"Bufi AA, Di Stefano J, Papait A, Silini AR, Parolini O, Ponsaerts P. The central role of CXCL10-CXCR3 signaling in neuroinflammation and neuropathology. Cytokine Growth Factor Rev. 2025;84:20\u201334.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"5","key":"1498_CR53","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1002\/hep4.1170","volume":"2","author":"KL de Graaf","year":"2018","unstructured":"de Graaf KL, Lapeyre G, Guilhot F, Ferlin W, Curbishley SM, Carbone M, et al. NI-0801, an anti-chemokine (C-X-C motif) ligand 10 antibody, in patients with primary biliary cholangitis and an incomplete response to ursodeoxycholic acid. Hepatol Commun. 2018;2(5):492\u2013503.","journal-title":"Hepatol Commun"},{"issue":"4","key":"1498_CR54","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1093\/ecco-jcc\/jjv224","volume":"10","author":"WJ Sandborn","year":"2016","unstructured":"Sandborn WJ, Colombel JF, Ghosh S, Sands BE, Dryden G, H\u00e9buterne X, et al. Eldelumab [anti-IP-10] induction therapy for ulcerative colitis: a randomised, placebo-controlled, phase 2b study. J Crohns Colitis. 2016;10(4):418\u201328.","journal-title":"J Crohns Colitis"}],"container-title":["Translational Stroke Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12975-026-01498-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12975-026-01498-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12975-026-01498-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T20:02:12Z","timestamp":1790971332000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12975-026-01498-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":54,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["1498"],"URL":"https:\/\/doi.org\/10.1007\/s12975-026-01498-7","relation":{},"ISSN":["1868-4483","1868-601X"],"issn-type":[{"value":"1868-4483","type":"print"},{"value":"1868-601X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"4 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Institutional Review Board of the University of Miami (IRB ID: MOD00014656; \u201cStroke Incidence and Risk Factors in a TriEthnic Region\u201d). Written informed consent for participation in the research was obtained from all participants. No identifiable participant data are included in this report.","order":1,"name":"Ethics","label":"Standard protocol approvals, registrations, and patient consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"MNS had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.","order":2,"name":"Ethics","label":"Data access statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"MSVE is a full-time employee of the American Heart Association. The other authors declare no competing interests.","order":3,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"107"}}